Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy
- 31 August 2004
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 93 (2) , 160-165
- https://doi.org/10.1016/s1081-1206(10)61469-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Quality of life measurement: bibliographic study of patient assessed health outcome measuresBMJ, 2002
- Patient, Clinician, and Population Perspectives on Determining the Clinical Significance of Quality-of-Life ScoresMayo Clinic Proceedings, 2002
- Assessing the Clinical Significance of Single Items Relative to Summated ScoresMayo Clinic Proceedings, 2002
- The Measurement of Quality of Life in Children: Past and Future PerspectivesJournal of Developmental & Behavioral Pediatrics, 2001
- Common Variable Immunodeficiency: Clinical and Immunological Features of 248 PatientsClinical Immunology, 1999
- Immunoglobulin replacement treatment by rapid subcutaneous infusionArchives of Disease in Childhood, 1998
- Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.Archives of Disease in Childhood, 1996
- The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusionsClinical and Experimental Immunology, 1993
- Measuring Health-Related Quality of LifeAnnals of Internal Medicine, 1993
- Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti-IgA antibodiesClinical and Experimental Allergy, 1986